1. Finsterer, Josef, Zarrouk-Mahjoub, Sinda. 2018. Phenotypic spectrum of SLC25A4 mutations. In Biomedical reports, 9, 119-122. doi:10.3892/br.2018.1115. https://pubmed.ncbi.nlm.nih.gov/30013777/
2. El-Hattab, Ayman W, Craigen, William J, Scaglia, Fernando. 2017. Mitochondrial DNA maintenance defects. In Biochimica et biophysica acta. Molecular basis of disease, 1863, 1539-1555. doi:10.1016/j.bbadis.2017.02.017. https://pubmed.ncbi.nlm.nih.gov/28215579/
3. Zhou, Ting, Pan, Jing, Xu, Kai, Song, Haixu, Han, Yaling. 2024. Single-cell transcriptomics in MI identify Slc25a4 as a new modulator of mitochondrial malfunction and apoptosis-associated cardiomyocyte subcluster. In Scientific reports, 14, 9274. doi:10.1038/s41598-024-59975-8. https://pubmed.ncbi.nlm.nih.gov/38654053/
4. Bround, Michael J, Havens, Julian R, York, Allen J, Karch, Jason, Molkentin, Jeffery D. 2023. ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy. In Science advances, 9, eadi2767. doi:10.1126/sciadv.adi2767. https://pubmed.ncbi.nlm.nih.gov/37624892/
5. Zhao, Huan, Shi, Min, Yang, Fang, Yang, Xuhong. . Kearns-Sayre syndrome with rare imaging finding of SLC25A4 Mutation. In Neurosciences (Riyadh, Saudi Arabia), 27, 111-115. doi:10.17712/nsj.2022.2.20210123. https://pubmed.ncbi.nlm.nih.gov/35477912/
6. Zhang, Ying, Wang, Yinghui, Zhang, Wenyan, Li, Ka, Zhang, Aijun. 2024. Comprehensive transcriptomic analysis identifies SLC25A4 as a key predictor of prognosis in osteosarcoma. In Frontiers in genetics, 15, 1410145. doi:10.3389/fgene.2024.1410145. https://pubmed.ncbi.nlm.nih.gov/38957810/
7. King, Martin S, Thompson, Kyle, Hopton, Sila, Taylor, Robert W, Ortiz-Gonzalez, Xilma R. 2018. Expanding the phenotype of de novo SLC25A4-linked mitochondrial disease to include mild myopathy. In Neurology. Genetics, 4, e256. doi:10.1212/NXG.0000000000000256. https://pubmed.ncbi.nlm.nih.gov/30046662/